NCT01793207View on ClinicalTrials.gov

Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population

CompletedOBSERVATIONAL

Enrollment

316

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Colorectal NeoplasmsAdenomaColorectal Tumors

Trial Locations (2)

Unknown

Kar-Alaini hospital (Cairo Univeristy hospital), Cairo

National cancer institute, Cairo

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

collaborator

science and technology development fund, Egypt

UNKNOWN

lead

Cairo University

OTHER

NCT01793207 - Peripheral Blood DNA Methylation Markers for the Early Detection of Colorectal Carcinoma in the Egyptian Population | Biotech Hunter | Biotech Hunter